IKZF3 - morinlab/LLMPP GitHub Wiki


bibliography: 'morinlab.bib' csl: 'NLM.csl' link-citations: true

IKZF3

Overview

IKZF3 (IKAROS family zinc finger 3, also known as AIOLOS) is a transcription factor involved in regulating B-cell development and function. Mutations in IKZF3 can lead to transcriptional dysregulation and contribute to the pathogenesis of B-cell neoplasms. IKZF3 is one of a number of genes affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. IKZF3 has multiple hot spot mutations in DLBCL. The most common, L162R, has been identified as a driver in CLL. In that context, it alters DNA binding specificity and causes hyperactivation of B-cell receptor (BCR) signaling and overexpression of NF-κB target genes.1 While primarily studied in CLL, the functional effects of IKZF3 mutations could have implications for other B-cell malignancies, including DLBCL

History

%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
    title Publication timing
      2013-08-15 : Morin : DLBCL
      2019-09-26 : Panea : BL
Loading

Relevance tier by entity

Entity Tier Description
BL 2-a aSHM target; Although recurrent, the relevance of mutations in BL is tenuous [@paneaWholeGenomeLandscape2019]
DLBCL 1-a aSHM target and high-confidence DLBCL gene [@morinMutationalStructuralAnalysis2013]

Mutation incidence in large patient cohorts (GAMBL reanalysis)

Entity source frequency (%)
BL GAMBL genomes+capture 1.62
BL Thomas cohort 0.80
BL Panea cohort 3.00
DLBCL GAMBL genomes 4.78
DLBCL Schmitz cohort 4.47
DLBCL Reddy cohort 3.90
DLBCL Chapuy cohort 4.27

Mutation pattern and selective pressure estimates

Entity aSHM Significant selection dN/dS (missense) dN/dS (nonsense)
BL Yes No 1.552 0
DLBCL Yes No 10.924 0
FL Yes No 7.180 0

aSHM regions

chr_name hg19_start hg19_end region regulatory_comment
chr17 37928959 37940119 TSS-1 NA
chr17 38015776 38024832 TSS-2 NA

IKZF3 Hotspots

Chromosome Coordinate (hg19) ref>alt HGVSp
chr17 37948968 T>C I128V
chr17 37948958 T>C N131S
chr17 37948950 T>C M134V
chr17 37948949 A>T M134K
chr17 37947783 T>G N160H
chr17 37947782 T>C N160S
chr17 37947776 A>C L162R
chr17 37944583 G>T Q213K
chr17 37944582 T>C Q213R
chr17 37944577 T>G S215R
chr17 37944575 A>T S215R
chr17 37944575 A>C S215R
chr17 37944568 C>T E218K
chr17 37944565 C>T E219K
chr17 37944564 T>A E219V
chr17 37944556 C>T E222K

View coding variants in ProteinPaint hg19 or hg38

View all variants in GenomePaint hg19 or hg38

IKZF3 Expression

References

  1. Lazarian, G., Yin, S., Hacken, E., Sewastianik, T., Uduman, M., Font-Tello, A., Gohil, S., Li, S., Kim, E., Joyal, H., Billington, L., Witten, E., Zheng, M., Huang, T., Severgnini, M., Lefebvre, V., Rassenti, L., Gutierrez, C., Georgopoulos, K., Ott, C., Wang, L., Kipps, T., Burger, J., Livak, K., Neuberg, D., Baran-Marszak, F., Cymbalista, F., Carrasco, R., & Wu, C. (2021). A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation.. Cancer cell, 39 3, 380-393.e8 . https://doi.org/10.1016/j.ccell.2021.02.003.
⚠️ **GitHub.com Fallback** ⚠️